Sugi Predict

Sugi Predict / Compounds / SCHEMBL1314197

SCHEMBL1314197

SCHEMBL1314197

CN(C)CCOC(=O)c1c(CC2CCN(Cc3cc(-c4ccccc4)no3)CC2)c(=O)c2ccccc2n1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 11/20 0.40
▸ MAPK9 P45984 7/20 0.40
▸ MAPK10 P53779 3/20 0.40
▸ TOP1 P11387 1/20 0.37
▸ IL4I1 Q96RQ9 2/20 0.36
▸ USP30 Q70CQ3 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ XIAP P98170 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1316873 0.90 MAPK8 (0.49) MAPK8MAPK9MAPK10TOP1
SCHEMBL12113280 0.81 MAPK8 (0.47) MAPK8MAPK9MAPK10
SCHEMBL12113329 0.80 MAPK8 (0.48) MAPK8MAPK9MAPK10ALDH1A1
Hydrochloric Acid SCHEMBL1313803 0.78 MAPK8 (0.46) MAPK8MAPK9MAPK10ALDH1A1
SCHEMBL1315551 0.69 MAPK8 (0.41) MAPK8MAPK9MAPK10MAPTL3MBTL1
SCHEMBL12116792 0.69 MAPK8 (0.58) MAPK8MAPK9MAPK10
SCHEMBL12112673 0.68 RAB9A (0.47) IL4I1USP30MAPTALDH1A1RAB9A
SCHEMBL12112674 0.68 IL4I1 (0.50) TOP1IL4I1USP30MAPT
SCHEMBL12113272 0.68 MAPK8 (0.61) MAPK8MAPK9MAPK10
Hydrochloric Acid SCHEMBL1314946 0.67 IL4I1 (0.49) TOP1IL4I1USP30MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 — — US disclosed
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 — — US disclosed
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 — — US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
EP-2375899-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF Array Biopharma, Inc. (US) 2011-10-19 — — EP disclosed
WO-2010080864-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2010-07-15 — — WO disclosed
WO-2010080864-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2010-07-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF NOS1, NOS2, ASS1 MAPK8 3189/4885MAPK9 1568/4885MAPK10 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.